VIRILIZATION OF THE VOICE IN POST-MENOPAUSAL WOMEN DUE TO THE ANABOLIC STEROID NANDROLONE DECANOATE (DECADURABOLIN). THE EFFECTS OF MEDICATION FOR ONE YEAR
Authors:
- 1 February 1994
- journal article
- clinical trial
- Published by Wiley in Clinical Otolaryngology
- Vol. 19 (1) , 79-84
Abstract
In a prospective study the effects on the voice of nandrolone decanoate super-imposed on cyclical hormonal replacement therapy (HRT) given to post-menopausal women suffering from a severe form osteoporosis were compared with the effects of HRT alone. Comparing the experimental group with the control group, after one year of medication in the experimental group a higher percentage of patients had: a lower fundamental frequency during speech, a loss of high frequencies and an increase in voice instability and creakiness. The lowering of the frequencies and the increase of instability can be explained by histological changes in the vocal cords and by problems in the adaptation to these histological changes.Keywords
This publication has 6 references indexed in Scilit:
- Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis?Bone and Mineral, 1992
- Androgen Abuse by AthletesEndocrine Reviews, 1988
- Intraspeaker variability in fundamental frequency stability: An age-related phenomenon?The Journal of the Acoustical Society of America, 1988
- Recommendation by the Union of European Phoniatricians (UEP): Standardizing Voice Area Measurement/PhonetographyFolia Phoniatrica et Logopaedica, 1983
- Die Beziehungen der Phoniatrie zur EndokrinologieFolia Phoniatrica et Logopaedica, 1968
- Voice Change in Adult Women Caused by Virilizing AgentsJournal of Speech and Hearing Disorders, 1967